InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Fulcrum Therapeutics, Inc.

FULC Clue Score33
United States Fiscal year ends December CIK 0001680581 Results filed 27 Apr 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

28
Insider
Date
Role
Action
Shares
Price
Amount
Robert J Gould
7 Jun 2022
Director
Sold after exercise
71,435
$8.09
$577.89K
Robert J Gould
6 Jun 2022
Director
Sold after exercise
24,382
$8.10
$197.59K
Robert J Gould
3 Jun 2022
Director
Sold after exercise
25,551
$7.95
$203.06K
Robert J Gould
2 Jun 2022
Director
Sold after exercise
16,689
$7.92
$132.16K
Robert J Gould
7 Apr 2022
Director
Sold after exercise
5,631
$24.02
$135.23K
Robert J Gould
5 Apr 2022
Director
Sold after exercise
52,552
$24.26
$1.27M
Robert J Gould
4 Apr 2022
Director
Sold after exercise
7,235
$24.02
$173.75K
Robert J Gould
1 Apr 2022
Director
Sold after exercise
34,464
$24.03
$828.16K
Bryan Stuart
11 Aug 2021
See Remarks
Sold after exercise
28,000
$23.75
$665.00K
Bryan Stuart
10 Aug 2021
See Remarks
Sold after exercise
32,000
$17.50
$560.00K
Christopher Moxham
10 Aug 2021
Chief Scientific Officer
Sold after exercise
31,071
$18.00
$559.28K
Christopher Moxham
10 Aug 2021
Chief Scientific Officer
Sold after exercise
20,714
$17.00
$352.14K
Peter G. Thomson
22 Feb 2021
VP Finance & Accounting
Sold after exercise
5,000
$14.72
$73.58K
Owen B. Wallace
8 Jul 2020
Chief Scientific Officer
Sold after exercise
2,951
$20.00
$59.02K
Owen B. Wallace
30 Jun 2020
Chief Scientific Officer
Sold after exercise
141
$20.00
$2.82K
Diego Cadavid
25 Jun 2020
SVP Clinical Development
Sold after exercise
1,459
$22.00
$32.10K
Diego Cadavid
10 Jun 2020
SVP Clinical Development
Sold after exercise
401
$22.00
$8.82K
Diego Cadavid
5 Jun 2020
SVP Clinical Development
Sold after exercise
451
$20.18
$9.10K
Diego Cadavid
4 Jun 2020
SVP Clinical Development
Sold after exercise
226
$20.05
$4.53K
Diego Cadavid
3 Jun 2020
SVP Clinical Development
Sold after exercise
338
$20.18
$6.82K
Diego Cadavid
2 Jun 2020
SVP Clinical Development
Sold after exercise
45
$20.00
$900.00
Diego Cadavid
29 May 2020
SVP Clinical Development
Sold after exercise
200
$20.04
$4.01K
Owen B. Wallace
28 May 2020
Chief Scientific Officer
Sold after exercise
2,232
$20.00
$44.64K
Diego Cadavid
28 May 2020
SVP Clinical Development
Sold after exercise
600
$20.00
$12.00K
Owen B. Wallace
27 May 2020
Chief Scientific Officer
Sold after exercise
448
$20.00
$8.96K
Owen B. Wallace
26 May 2020
Chief Scientific Officer
Sold after exercise
412
$20.00
$8.24K
Diego Cadavid
12 May 2020
SVP Clinical Development
Sold after exercise
1,860
$18.00
$33.48K
Owen B. Wallace
19 Feb 2020
Chief Scientific Officer
Sold after exercise
6,088
$20.00
$121.76K
Show all 98 transactions →

What was left out

Form 4 filings counted 183
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 16
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 28
Sales at will 41
Transactions with no price 0
Shares from compensation/vesting 32,104,196
Sales filed before the plan box existed 29
History held since 18 Jul 2019